Industry Supported Sessions Saturday, November 4, 2017 13:00 -14:30 Hall B THE KEY ROLE OF QUALITY OF LIFE IN THE LONG-DISTANCE RACE OF OVARIAN CANCER Symposium Organized by: PharmaMar CHAIR: Andreas Du Bois, Germany 13:00 WELCOME AND INTRODUCTION Andreas Du Bois, Germany 13:05 SETTING THE SCENE: QUALITY OF LIFE IN OVARIAN CANCER, IS IT A KEY FACTOR FOR OUR DECISION MAKING? Felix Hilpert, Germany 13:25 BEING PRACTICAL Case 1: Isabelle Ray-Coquard , France Case 2: Nicoletta Colombo, Italy Case 3: Christian Marth, Austria 14.25 CLOSING AND REMARKS Andreas Du Bois, Germany 17:00 -18:00 Hall A NEW PERSPECTIVES ON PARP INHIBITION Symposium Organized by: TESARO CHAIRS: Christian Marth, Austria and Andreas du Bois, Germany 17:15 WELCOME AND INTRODUCTION Christian Marth, Austria 17:20 RECURRENT OVARIAN CANCER: WHAT DOES MAINTENANCE THERAPY OFFER? Nicoletta Colombo, Italy 17:35 WHICH PATIENTS WITH RECURRENT OVARIAN CANCER CAN BENEFIT FROM PARP INHIBITOR MAINTENANCE THERAPY AND FOR HOW LONG? Susana Banerjee, UK 17:55 HOW TO USE NIRAPARIB IN RECURRENT OVARIAN CANCER AND THE IMPACT ON PATIENT QUALITY OF LIFE Mansoor Mirza, Denmark 18:10 CONCLUSION Andreas du Bois, Germany Sunday, November 5, 2017 07:30 – 08:30 Hall M FIRST CLINICAL EXPERIENCES WITH NIRAPARIB Symposium Organized by: TESARO CHAIR: Jalid Sehouli, Germany 07:30 Introduction Jalid Sehouli, Germany 07:40 Practical experiences from Klinik für Gynäkologie, Die Charité – Universitätsmedizin Berlin, Germany Jacek Grabowski, Germany 08:00 Discussion - Q & A 08:05 Practical experiences from CTCA at Southeastern Regional Medical Center, Georgia USA John P. Geisler, USA 08:25 Discussion - Q & A 08:30 Close 13:00 – 14:30 Hall A FRONT-LINE OVARIAN CANCER: CAN WE DO BETTER? TODAY, TOMORROW Symposium Organized by: Roche CHAIR: Sandro Pignata, Italy With a multidisciplinary expert tumour board, this interactive and educational session will review the progress that has been made with front-line ovarian cancer treatment, including neoadjuvant and adjuvant therapy, surgery, and targeted treatments. Chaired by Sandro Pignata, the tumour board will discuss the key considerations to have and main challenges faced when making front-line decisions for ovarian cancer; and consider ways in which we can do better for patients - now and in the future. Speakers: Roman Rouzier, Sven Mahner, Nicoletta Colombo, Kathleen Moore 16:00 – 17:00 Hall A HPV vaccination - Lessons Learned and the Future Symposium Organized by: Merck CHAIR: Elmar Joura, Austria 16:00 Welcome and Opening Remarks Elmar Joura, Austria 16:05 From a 4vHPV to 9vHPV Vaccine—Setting Aspirations for the Future Elmar Joura, Austria 16:25 HPV vaccination experience in prevention of recurrence Alessandro Ghelardi, Italy 16:40 HPV Vaccination Population Coverage Xavier Bosch, Spain 16:50 Q and A Hall B VIDEO TEACHING SESSION: “THE FUTURE OF PELVIC SURGERY: MAXIMIZING PATIENT OUTCOMES AND QOL Symposium Organized by: ETHICON CHAIR: Jalid Sehouli, Germany 16:00 PELVIC SIDE WALL SURGERY AND COMPLICATIONS Jalid Sehouli, Germany 16:20 PELVIC NERVE SPARING TECHNIQUES AND COMPLICATIONS Vito Chiantera, Italy 16:40 PELVIC VASCULAR SURGERY AND COMPLICATIONS Santiago Domingo, Spain Monday, November 6, 2017 13:00-14:30 Hall B Bringing clarity to PARP inhibitor use in ovarian cancer Symposium Organized by: AstraZeneca CHAIR: Nicoletta Colombo, Italy 13:00 CLARITY THROUGH UNDERSTANDING – ADDRESSING PATIENT NEEDS 13:05 WELCOME AND INTRODUCTION Nicoletta Colombo, Italy 13:10 TARGETING THE DNA DAMAGE RESPONSE – CLARIFYING THE RATIONALE FOR PARP INHIBITION Rebecca Kristeleit, UK 13:25 MAINTAINING CONTROL WITH PARP INHIBITORS Nicoletta Colombo, Italy 13:40 MAINTAINING CONTROL WITH PARP INHIBITORS Nicoletta Colombo, Italy 13:40 PARP INHIBITORS – TRANSLATING EVIDENCE TO CLINICAL PRACTICE Philipp Harter, Germany 13:55 TAILORED TREATMENT – SELECTING THE RIGHT PATIENT FOR PARP INHIBITION Nicoletta Colombo, Italy 14:10 ILLUMINATION SESSION All 14:25 SUMMARY AND CLOSE Nicoletta Colombo, Italy 16:00 -17:00 Hall B IMMUNOTHERAPY: NEW STRATEGIES FOR THE TREATMENT OF CERVICAL CANCER Symposium Organized by: ADVAXIS CHAIR: Christian Marth, Austria 16:00 OPENING AND INTROCUTION OF SPEAKER PANEL Christian Marth, Austria 16:05 MOA OF THE IMMUNOTHERAPY AXALIMOGENE FILOSLISBAC (AXAL) AND COMPARISON TO OTHER IMMUNOTHERAPIES Sandro Pignata, Italy 16:20 PHASE 3 CLINICAL TRIAL OF AXAL IN COMBINATION WITH PD-1 IN METASTATIC CERVICAL CANCER Christian Marth, Austria 16:35 AXAL CLINICAL DATA IN METASTATIC CERVICAL CANCER Sharad Ghamande, USA 16:50 Q&A Hall C PARP Inhibition and Ovarian Cancer: Leading the Field in Exploiting DNA Repair as a Therapeutic Target Symposium Organized by: Prime Oncology CHAIR: Nicoletta Colombo, Italy 16:00 Welcome and introduction Nicoletta Colombo, Italy 16:02 Introductory quiz Nicoletta Colombo, Italy 16:05 Everything a clinician needs to know about DNA repair and PARP inhibition Thomas Helleday, Sweden 16:20 A new string to the bow in the treatment of advanced ovarian cancer Bradley Monk, USA 16:35 Clinical application of PARP inhibitors: Proactive management of adverse events Rebecca Kristeleit, United Kingdom 16:45 Q&A and faculty discussion 16:53 PARP inhibition and ovarian cancer: Have we convinced you? Nicoletta Colombo, Italy 16:58 prIME PointsTM Nicoletta Colombo, Italy 17:00 Adjourn Not yet an ESGO member? Join or renew today Directly to: Programme Abstract Submission Registration Book your hotel ESGO 2017 Newsletter Get notified on all news and activities right in your mailbox. Sign-up Now! You may also like Congress Highlights Read More Vienna Landmarks Read More Hotels in Vienna Read More Register Now & Save Read More ESGO 2017 Congress ESGO’s International meeting is Europe’s landmark meeting in Gynaecological Oncology and the core of ESGO’s educational activities. Held biennially, ESGO congress offers professionals a unique opportunity to learn and discuss the latest medical and scientific developments in gynaecological cancers research, treatment and care, as well as to network with key opinion leaders and peers from around the world. Read more Why Attend Key Reasons Highlights Congress Webcasts Scientific Info Congress Highlights Abstract Submission Scientific Programme Congress Info Committees Key Dates FAQ About ESGO Congress Become a Member eAcademy News Updates Get notified on all of ESGO’s news and activities. Sign-up Now!